These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8768872)

  • 1. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
    Otto EA; Ochs K; Hansen C; Wall JR; Kahaly GJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune endocrine ophthalmopathy and retrobulbar antigens.
    Otto E; Ochs K; Leyendecker E; Gentsch A; Hansen C; Beyer J; Kahaly G
    Horm Metab Res; 1995 Dec; 27(12):533-8. PubMed ID: 8750781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.
    Grubeck-Loebenstein B; Trieb K; Sztankay A; Holter W; Anderl H; Wick G
    J Clin Invest; 1994 Jun; 93(6):2738-43. PubMed ID: 8201012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.
    de Carli M; D'Elios MM; Mariotti S; Marcocci C; Pinchera A; Ricci M; Romagnani S; del Prete G
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1120-4. PubMed ID: 8077301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
    Heufelder AE
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibroblast is the target cell in the connective tissue manifestations of Graves' disease.
    Bahn RS
    Int Arch Allergy Immunol; 1995 Mar; 106(3):213-8. PubMed ID: 7888783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy.
    Stover C; Otto E; Beyer J; Kahaly G
    Thyroid; 1994; 4(2):161-5. PubMed ID: 7919998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune damage in Graves' ophthalmopathy.
    Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
    Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue.
    McLachlan SM; Prummel MF; Rapoport B
    J Clin Endocrinol Metab; 1994 May; 78(5):1070-4. PubMed ID: 8175962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
    Mizokami T; Salvi M; Wall JR
    J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
    Hiromatsu Y; Fukazawa H; How J; Wall JR
    Clin Exp Immunol; 1987 Dec; 70(3):593-603. PubMed ID: 3124997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.